The Wien Center for Alzheimer’s
Disease and Memory Disorders, Mount Sinai Medical Center, Miami
Beach will present the:
• 11th Mild
Cognitive Impairment (MCI) Symposium (Saturday, January 19),
• 2nd Early
Alzheimer’s Diagnostic and Treatment Workshop (Sunday morning,
January 20), and
1st Mount Sinai of Florida's Early Alzheimer's Public Educational Forum (Sunday afternoon, January 20)
Beach, Florida, USA.
symposium's theme will be centered on the progression rates from
normal to mild cognitive impairment and then to dementia.
Symposium series was initiated in 2003 by the Wien Center for
Alzheimer’s Disease and Memory Disorders, at Mount Sinai Medical
Center, Miami Beach, under the direction of Ranjan Duara, MD.
The purpose of the first and subsequent symposia have been to
provide a forum where new information is provided and in-depth
discussions can take place about the earliest stages of
Alzheimer’s disease and other conditions that result in
cognitive impairment in the elderly. The symposia have featured
national and international experts in the fields of neurology,
neuropsychology, psychiatry, geriatrics, epidemiology, genetics,
imaging and neuropathology. The topics discussed at these
symposia have included the biology, early detection, prevention
and treatment of conditions that result in cognitive impairment
in the elderly.
The MCI Symposium
and the Early Alzheimer's Diagnostic and Treatment Workshop will
attract: Neurologists, Psychiatrists, Geriatricians,
Gerontologists, Epidemiologists, Neuropsychologists,
The 1st Mount Sinai of Florida's Early Alzheimer's Public Educational Forum will attract individuals with Alzheimer's
disease, at-risk family members and caregivers.
epidemiological and community studies that have examined
demographic, medical, psychological and genetic factors that
influence progression rates;
we measure clinical and biological progression of the disease
(using functional and neuropsychological measures, as well as
biomarkers) and the different perspectives of disease
progression provided by different modalities;
we assess response to interventions.
To provide formal and informal networking opportunities.
To create a translational and educational segment for the
Participants who wish
to present a poster at the event, may submit an
abstract which will be reviewed by the Program
Committee. Results of this review will be
communicated via email, to each applicant. Please
note the conference program will only include the
abstracts of registered conference participants - no
exceptions will be made.
of the event
Visit our Facebook and LinkedIn groups
for ongoing updates!
As in 2012, this event
will be held back to back with the
7th Human Amyloid Imaging (HAI)
Conference (www.worldeventsforum.com/hai). This
event will be presented at the same venue between January 16-18,